COVID Intel - by William Makis (McGill Medicine)

COVID Intel - by William Makis (McGill Medicine)

BREAKING NEWS: MEBENDAZOLE Patent for treatment of CANCER Unearthed

William Makis's avatar
William Makis
Nov 18, 2025
∙ Paid

PATENT LINK:

BREAKING NEWS: MEBENDAZOLE PATENT for CANCER Treatment Uncovered!


You know those low IQ people (including many doctors) who use the term “dewormer”?

Mebendazole is an “animal dewormer” like Ivermectin and Fenbendazole.

On Sep.7, 2021, Johns Hopkins University in Baltimore, MD secured a patent for MEBENDAZOLE for this use:

1. Repurposed for Glioblastoma Therapy

(as an oral drug mebendazole polymorph C is a superior form, and it reaches the brain and brain tumors in effective concentrations)

2. May also be used for therapy of other cancers, as well as a chemo-preventative agent.

The title of the patent: “Mebendazole Polymorph for Treatment and Prevention of Tumors”

I will let that sink in.

This is what I have been working with for the past 2 years.

Everyone who has attacked me up to now, none of them ever talk about this Patent.

The WAR on terminally ill cancer patients who are exercising their “Right to Try” is real and very EVIL

If you see anyone attacking me, you will know why.

Give a gift subscription

Share

Keep reading with a 7-day free trial

Subscribe to COVID Intel - by William Makis (McGill Medicine) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 William Makis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture